AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of Glytactin BUILD, a unique medical food formula for the dietary management of Phenylketonuria (PKU). This latest addition to the glytactin family of PKU products was designed to enhance availability of the specialized glytactin protein for those on a low phenylalanine diet seeking more protein and fewer calories than traditional PKU Medical Foods.
At only 54 calories per 10 grams of Glytactin protein, Glytactin BUILD is the lowest calorie GMP-based formula available. With a complete profile of vitamins and minerals as well as probiotics to support digestive health, Glytactin BUILD is a versatile powder with a neutral flavor to be taken alone or as a way to build up the protein level of other PKU formulas or low protein food items. Glytactin BUILD has a pH equivalent to water that helps ease the GI distress associated with consuming traditional PKU formulas made from synthetically derived amino acids. Each convenient stick pack contains 10 grams of protein equivalent glytactin and is sold with 30 sticks per box.
“I started adding Glytactin BUILD to my current formula to boost the protein level and smooth out the amino acid burn,” said Melinda S. “When I do, my stomach feels better, so I feel better.”
“I want all my patients to use a more natural protein, but many of them have grown accustomed to the old-fashioned amino acid formula they grew up using,” said a registered dietitian from a metabolic clinic on the west coast. “Glytactin BUILD is a great protein additive that lets me introduce natural protein into their diets while also taking care of their GI health and managing their caloric intake.”
Glytactin is made from a natural whole protein derived from whey called glycomacropeptide (GMP), which is very low in phenylalanine. Published clinical evidence conducted at the University of Wisconsin, Madison, suggests intact proteins made with GMP have important benefits for patients with PKU versus traditional synthetic amino acid based formulas. These benefits include: improved taste, increased satiety, lower dietary acid load and improved protein utilization.
About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.